South State Corp Novo Nordisk A S Transaction History

South State Corp

$1.52 Billion
Q4 2024

A detailed history of South State Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, South State Corp holds 49,251 shares of NVO stock, worth $4.46 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

49,251

Previous 50,725 2.91%

Holding current value

$4.46 Million

Previous $6.04 Million 29.86%

% of portfolio

0.28%

Previous 0.42%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$85.0 - $120.04 $125,290 - $176,938	-1,474 Reduced 2.91%	49,251 $4.24 Million
Q3 2024 Nov 08, 2024	SELL	$119.07 - $145.42 $814,676 - $994,963	-6,842 Reduced 11.89%	50,725 $6.04 Million
Q2 2024 Aug 02, 2024	SELL	$122.71 - $146.91 $223,823 - $267,963	-1,824 Reduced 3.07%	57,567 $8.22 Million
Q1 2024 May 06, 2024	BUY	$102.11 - $135.92 $660,958 - $879,810	6,473 Added 12.23%	59,391 $7.63 Million
Q4 2023 Feb 06, 2024	SELL	$87.78 - $105.45 $133,776 - $160,705	-1,524 Reduced 2.8%	52,918 $5.47 Million
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $2.54 Million - $5.57 Million	27,906 Added 105.16%	54,442 $4.95 Million
Q2 2023 Aug 08, 2023	BUY	$155.98 - $172.65 $65,823 - $72,858	422 Added 1.62%	26,536 $4.29 Million
Q1 2023 May 08, 2023	SELL	$132.34 - $159.14 $510,567 - $613,962	-3,858 Reduced 12.87%	26,114 $4.16 Million
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $168,592 - $222,482	-1,644 Reduced 5.2%	29,972 $4.06 Million
Q3 2022 Nov 07, 2022	BUY	$95.28 - $116.93 $59,264 - $72,730	622 Added 2.01%	31,616 $3.15 Million
Q2 2022 Aug 05, 2022	SELL	$103.24 - $121.81 $60,601 - $71,502	-587 Reduced 1.86%	30,994 $3.45 Million
Q1 2022 May 06, 2022	BUY	$93.1 - $112.54 $384,782 - $465,127	4,133 Added 15.06%	31,581 $3.51 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $55,322 - $67,555	-577 Reduced 2.06%	27,448 $3.08 Million
Q3 2021 Nov 10, 2021	SELL	$84.42 - $106.62 $38,833 - $49,045	-460 Reduced 1.61%	28,025 $2.69 Million
Q2 2021 Aug 10, 2021	SELL	$67.66 - $84.76 $140,597 - $176,131	-2,078 Reduced 6.8%	28,485 $2.39 Million
Q1 2021 May 12, 2021	SELL	$67.06 - $75.82 $59,683 - $67,479	-890 Reduced 2.83%	30,563 $2.06 Million
Q4 2020 Feb 10, 2021	SELL	$63.89 - $73.8 $47,725 - $55,128	-747 Reduced 2.32%	31,453 $2.2 Million
Q3 2020 Nov 10, 2020	SELL	$63.69 - $70.22 $23,246 - $25,630	-365 Reduced 1.12%	32,200 $2.24 Million
Q2 2020 Aug 11, 2020	SELL	$58.54 - $67.94 $8,781 - $10,191	-150 Reduced 0.46%	32,565 $2.13 Million
Q1 2020 May 04, 2020	SELL	$49.46 - $64.78 $283,900 - $371,837	-5,740 Reduced 14.93%	32,715 $1.97 Million
Q4 2019 Feb 05, 2020	SELL	$49.86 - $58.26 $69,305 - $80,981	-1,390 Reduced 3.49%	38,455 $2.23 Million
Q3 2019 Nov 08, 2019	SELL	$47.54 - $53.43 $363,443 - $408,472	-7,645 Reduced 16.1%	39,845 $2.06 Million
Q2 2019 Aug 13, 2019	SELL	$46.79 - $52.47 $268,808 - $301,440	-5,745 Reduced 10.79%	47,490 $2.42 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $13,908 - $15,789	-300 Reduced 0.56%	53,235 $2.78 Million
Q3 2018 Nov 08, 2018	SELL	$46.76 - $51.24 $37,267 - $40,838	-797 Reduced 1.47%	53,535 $2.52 Million
Q2 2018 Aug 03, 2018	SELL	$44.29 - $50.42 $19,177 - $21,831	-433 Reduced 0.79%	54,332 $2.51 Million
Q1 2018 May 11, 2018	SELL	$48.49 - $58.14 $37,094 - $44,477	-765 Reduced 1.38%	54,765 $2.7 Million
Q4 2017 Feb 12, 2018	BUY	$47.53 - $53.73 $134,557 - $152,109	2,831 Added 5.37%	55,530 $2.98 Million
Q3 2017 Nov 09, 2017	SELL	$41.15 - $49.22 $6,172 - $7,383	-150 Reduced 0.28%	52,699 $2.54 Million
Q2 2017 Aug 10, 2017	BUY	N/A	52,849	52,849 $2.27 Million

Others Institutions Holding NVO

# of Institutions

1,884

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $205B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.

Account